nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—Adverse reaction—Riluzole—amyotrophic lateral sclerosis	0.0749	0.0877	CcSEcCtD
Paricalcitol—Reaction aggravation—Riluzole—amyotrophic lateral sclerosis	0.0749	0.0877	CcSEcCtD
Paricalcitol—Parathyroid disorder—Riluzole—amyotrophic lateral sclerosis	0.0681	0.0798	CcSEcCtD
Paricalcitol—Condition aggravated—Riluzole—amyotrophic lateral sclerosis	0.043	0.0504	CcSEcCtD
Paricalcitol—Peritonitis—Riluzole—amyotrophic lateral sclerosis	0.0311	0.0364	CcSEcCtD
Paricalcitol—VDR—forelimb—amyotrophic lateral sclerosis	0.0211	0.363	CbGeAlD
Paricalcitol—VDR—hindlimb—amyotrophic lateral sclerosis	0.019	0.327	CbGeAlD
Paricalcitol—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0193	CcSEcCtD
Paricalcitol—VDR—appendage—amyotrophic lateral sclerosis	0.0163	0.28	CbGeAlD
Paricalcitol—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0162	0.019	CcSEcCtD
Paricalcitol—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0153	CcSEcCtD
Paricalcitol—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0132	CcSEcCtD
Paricalcitol—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0131	CcSEcCtD
Paricalcitol—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0123	CcSEcCtD
Paricalcitol—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0122	CcSEcCtD
Paricalcitol—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0118	CcSEcCtD
Paricalcitol—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00969	0.0114	CcSEcCtD
Paricalcitol—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00947	0.0111	CcSEcCtD
Paricalcitol—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00913	0.0107	CcSEcCtD
Paricalcitol—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.009	0.0105	CcSEcCtD
Paricalcitol—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00864	0.0101	CcSEcCtD
Paricalcitol—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00858	0.0101	CcSEcCtD
Paricalcitol—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0083	0.00973	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00805	0.0906	CbGpPWpGaD
Paricalcitol—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00805	0.00943	CcSEcCtD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00775	0.0873	CbGpPWpGaD
Paricalcitol—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00758	0.00889	CcSEcCtD
Paricalcitol—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00737	0.00864	CcSEcCtD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00718	0.0808	CbGpPWpGaD
Paricalcitol—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0071	0.00832	CcSEcCtD
Paricalcitol—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00699	0.00819	CcSEcCtD
Paricalcitol—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00681	0.00799	CcSEcCtD
Paricalcitol—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00783	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0065	0.0731	CbGpPWpGaD
Paricalcitol—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00615	0.0072	CcSEcCtD
Paricalcitol—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00599	0.00702	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00594	0.0669	CbGpPWpGaD
Paricalcitol—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00687	CcSEcCtD
Paricalcitol—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00668	CcSEcCtD
Paricalcitol—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00668	CcSEcCtD
Paricalcitol—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00565	0.00663	CcSEcCtD
Paricalcitol—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00652	CcSEcCtD
Paricalcitol—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00635	CcSEcCtD
Paricalcitol—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00621	CcSEcCtD
Paricalcitol—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00604	CcSEcCtD
Paricalcitol—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00602	CcSEcCtD
Paricalcitol—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00591	CcSEcCtD
Paricalcitol—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00577	CcSEcCtD
Paricalcitol—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00577	CcSEcCtD
Paricalcitol—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00577	CcSEcCtD
Paricalcitol—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00566	CcSEcCtD
Paricalcitol—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00554	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0047	0.0529	CbGpPWpGaD
Paricalcitol—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00532	CcSEcCtD
Paricalcitol—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00522	CcSEcCtD
Paricalcitol—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00518	CcSEcCtD
Paricalcitol—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00515	CcSEcCtD
Paricalcitol—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00515	CcSEcCtD
Paricalcitol—Depression—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00513	CcSEcCtD
Paricalcitol—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00427	0.005	CcSEcCtD
Paricalcitol—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00494	CcSEcCtD
Paricalcitol—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00486	CcSEcCtD
Paricalcitol—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00483	CcSEcCtD
Paricalcitol—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0046	CcSEcCtD
Paricalcitol—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00459	CcSEcCtD
Paricalcitol—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00456	CcSEcCtD
Paricalcitol—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00455	CcSEcCtD
Paricalcitol—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00454	CcSEcCtD
Paricalcitol—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00453	CcSEcCtD
Paricalcitol—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00432	CcSEcCtD
Paricalcitol—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00429	CcSEcCtD
Paricalcitol—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00419	CcSEcCtD
Paricalcitol—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00417	CcSEcCtD
Paricalcitol—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00417	CcSEcCtD
Paricalcitol—Chills—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00415	CcSEcCtD
Paricalcitol—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00413	CcSEcCtD
Paricalcitol—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00408	CcSEcCtD
Paricalcitol—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00405	CcSEcCtD
Paricalcitol—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00402	CcSEcCtD
Paricalcitol—Tension—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00395	CcSEcCtD
Paricalcitol—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00394	CcSEcCtD
Paricalcitol—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00391	CcSEcCtD
Paricalcitol—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00389	CcSEcCtD
Paricalcitol—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00387	CcSEcCtD
Paricalcitol—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00373	CcSEcCtD
Paricalcitol—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00372	CcSEcCtD
Paricalcitol—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00315	0.0037	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.00315	0.0354	CbGpPWpGaD
Paricalcitol—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00368	CcSEcCtD
Paricalcitol—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00363	CcSEcCtD
Paricalcitol—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00361	CcSEcCtD
Paricalcitol—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00361	CcSEcCtD
Paricalcitol—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00307	0.0036	CcSEcCtD
Paricalcitol—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00356	CcSEcCtD
Paricalcitol—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00354	CcSEcCtD
Paricalcitol—Cough—Riluzole—amyotrophic lateral sclerosis	0.003	0.00351	CcSEcCtD
Paricalcitol—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00347	CcSEcCtD
Paricalcitol—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00343	CcSEcCtD
Paricalcitol—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00343	CcSEcCtD
Paricalcitol—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00343	CcSEcCtD
Paricalcitol—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00341	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0029	0.0034	CcSEcCtD
Paricalcitol—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00338	CcSEcCtD
Paricalcitol—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00335	CcSEcCtD
Paricalcitol—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00331	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.00282	0.0317	CbGpPWpGaD
Paricalcitol—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00328	CcSEcCtD
Paricalcitol—Infection—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00326	CcSEcCtD
Paricalcitol—Shock—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00323	CcSEcCtD
Paricalcitol—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00322	CcSEcCtD
Paricalcitol—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00319	CcSEcCtD
Paricalcitol—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00317	CcSEcCtD
Paricalcitol—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00313	CcSEcCtD
Paricalcitol—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00307	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00299	CcSEcCtD
Paricalcitol—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00297	CcSEcCtD
Paricalcitol—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00295	CcSEcCtD
Paricalcitol—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00293	CcSEcCtD
Paricalcitol—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00292	CcSEcCtD
Paricalcitol—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00289	CcSEcCtD
Paricalcitol—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00285	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00283	CcSEcCtD
Paricalcitol—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00283	CcSEcCtD
Paricalcitol—Pain—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00281	CcSEcCtD
Paricalcitol—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00281	CcSEcCtD
Paricalcitol—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00271	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00269	CcSEcCtD
Paricalcitol—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00261	CcSEcCtD
Paricalcitol—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0026	CcSEcCtD
Paricalcitol—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0026	CcSEcCtD
Paricalcitol—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00242	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00204	0.0229	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00201	0.0226	CbGpPWpGaD
Paricalcitol—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00236	CcSEcCtD
Paricalcitol—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00232	CcSEcCtD
Paricalcitol—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00225	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00186	0.0209	CbGpPWpGaD
Paricalcitol—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00217	CcSEcCtD
Paricalcitol—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00209	CcSEcCtD
Paricalcitol—Rash—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00207	CcSEcCtD
Paricalcitol—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00207	CcSEcCtD
Paricalcitol—Headache—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00206	CcSEcCtD
Paricalcitol—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00195	CcSEcCtD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00161	0.0181	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00155	0.0174	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00154	0.0174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00142	0.0159	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00136	0.0153	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00132	0.0148	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—IGFBP3—amyotrophic lateral sclerosis	0.00131	0.0148	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00124	0.0139	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00123	0.0139	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00105	0.0118	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00101	0.0113	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000981	0.011	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0009	0.0101	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000888	0.01	CbGpPWpGaD
Paricalcitol—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000866	0.0149	CbGeAlD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000849	0.00956	CbGpPWpGaD
Paricalcitol—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000834	0.0144	CbGeAlD
Paricalcitol—VDR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000834	0.00939	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000821	0.00924	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000811	0.00913	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000743	0.00837	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00072	0.0081	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00071	0.00799	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00069	0.00777	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00069	0.00777	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000643	0.00724	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000631	0.0071	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000587	0.0066	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000552	0.00621	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000552	0.00621	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000552	0.00621	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000515	0.0058	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000504	0.00568	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000499	0.00561	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000479	0.00539	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000469	0.00528	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000464	0.00522	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000441	0.00496	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000399	0.00449	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000391	0.0044	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000378	0.00426	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000349	0.00393	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000318	0.00358	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000302	0.0034	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000286	0.00322	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000279	0.00314	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP53—amyotrophic lateral sclerosis	0.000274	0.00309	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000261	0.00294	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000261	0.00294	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000229	0.00258	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000179	0.00202	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000154	0.00173	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000141	0.00159	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000123	0.00139	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000117	0.00132	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000116	0.00131	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000115	0.0013	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.00127	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.31e-05	0.00105	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	8.95e-05	0.00101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	8.95e-05	0.00101	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.19e-05	0.000922	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.98e-05	0.000898	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.61e-05	0.000857	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.16e-05	0.000806	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.47e-05	0.000729	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.38e-05	0.000718	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	4.91e-05	0.000552	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.53e-05	0.00051	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.72e-05	0.000419	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2e-05	0.000225	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.84e-05	0.000207	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.51e-05	0.00017	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.04e-05	0.000117	CbGpPWpGaD
